Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640.

Antoon JW, White MD, Meacham WD, Slaughter EM, Muir SE, Elliott S, Rhodes LV, Ashe HB, Wiese TE, Smith CD, Burow ME, Beckman BS. Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640. Endocrinology. 2010 Nov; 151(11):5124-35.

View in: PubMed

subject areas

Adamantane
Analysis of Variance
Animals
Blotting, Western
Cell Line
Cell Proliferation
Cell Survival
Cells, Cultured
Estradiol
Female
Gene Expression
Humans
Immunohistochemistry
Mice
Phosphorylation
Phosphotransferases (Alcohol Group Acceptor)
Pyridines
Receptors, Estrogen
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction
Transcription, Genetic

authors with profiles

Thomas E. Wiese

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support